BioLink
PrivateLast Round
Strategic
Nov 14, 2024
Company Overview
BioLink operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series A Extension round in February 2024.
BioLink is a life sciences company that provides process solutions, equipment, and consumables for the manufacturing of biopharmaceuticals, including vaccines, antibodies, and cell and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Pharma Supply Chain, Smart Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioLink Comparables
Compare BioLink with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bestchrom (Shanghai) Biosciences Ltd. | 81% | |
| Cobetter Filtration | 81% | |
| Lisure Science (Suzhou) Co., Ltd. | 80% |
For institutional investors. Book with your work email.
BioLink Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Nov 14, 2024 | ||||
| Series A Extension | Feb 21, 2024 | ||||
| Series A | Dec 1, 2022 |
For institutional investors. Book with your work email.
BioLink Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cathay Capital | Series A Extension, Series A, Strategic |
| Alwin Capital | Strategic |
| Boyu Capital | Series A |
| Zoo Capital | Strategic |
| Shenzhen Capital Group | Strategic |
| Apricot Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
Grew 20% QoQ, from 45 to 54 employees.
- Dec 26, 2025
Grew 16% QoQ, from 45 to 52 employees.
For institutional investors. Book with your work email.
BioLink Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioLink's valuation, stock price, and market status.
Is BioLink a public or private company?
BioLink is a private company.
What is the current stock price of BioLink?
BioLink is a private company, so its shares have no public market price. Caplight tracks BioLink's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioLink worth (valuation)?
Valuation information for BioLink is not publicly available.
Can I buy BioLink stock?
BioLink shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioLink's last funding round?
BioLink's most recent funding round was Strategic on November 14, 2024.
Who are the main investors in BioLink?
Key investors in BioLink include Cathay Capital.
Will BioLink IPO soon?
No public IPO plans have been announced for BioLink.
How can I track BioLink secondary market activity?
Caplight tracks bids, offers, and trades in BioLink's shares on secondary markets.